![Armata Pharmaceuticals, Inc. logo](/logos/ARMP.webp)
Armata Pharmaceuticals, Inc.
AMEX:ARMP
Overview | Financials
Company Name | Armata Pharmaceuticals, Inc. |
Symbol | ARMP |
Currency | USD |
Price | 2.22 |
Market Cap | 80,202,606 |
Dividend Yield | 0% |
52-week-range | 0.83 - 5.26 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Dr. Deborah L. Birx M.D. |
Website | https://www.armatapharma.com |
An error occurred while fetching data.
About Armata Pharmaceuticals, Inc.
Armata Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It develops its products using its proprietary bacteriophage-based technology. The company's product candidates include AP-SA02 for the treatment of Staphylococcus aureus bacteremia; AP-PA02 for Pseudomonas aeruginosa; and AP-PA03 for the treatment
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD